COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • May 27th, 2020 • Genfit S.A. • Biological products, (no disgnostic substances) • New York
This Collaboration and License Agreement (the “Agreement”) is entered into as of June 24, 2019 (the “Effective Date”) by and between Genfit SA, a corporation organized and existing under the laws of France and having a place of business at Parc Eurasanté, 885 avenue Eugène Avinée, 59120 Loos, France (“Genfit”), and Terns Pharmaceutical, Inc., an exempted company organized and existing under the laws of the Cayman Islands and having a place of business at P. O. Box 613, Harbor Center, George Town, Grand Cayman KY1-1107, Cayman Islands (“Terns”). Genfit and Terns are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
